All CIRM Grants

Search Filters »

Disease Focus

Institution

Program Type

Grant Type

Human Stem Cell Use

Cell Line Generation

Collaborative Funder

Award Status

Institution Researcher name Grant Type Grant Title Award Value
Stanford University Dr. Joseph C. Wu Conference II Stanford Drug Discovery Symposium 2024 $15,000
University of California, San Diego Dr. Adam Engler Conference II BIC 2024 – 24th Annual UC Systemwide Symposium on Bioengineering at UC San Diego $50,000
University of California, Berkeley Dr. Regis Kelly Conference II Immunotherapy of Brain Disorders $23,376
Novoglia, Inc. Dr. Sunil Gandhi Ph.D Conference II ALSP Community Conference: Insights and Potential of Cell-Based Therapies for the Treatment of Leukodystrophies $48,500
University of Southern California Dr. Yang Chai Conference II 2023 Dental, Oral, & Craniofacial Tissue Regeneration Consortium (DOCTRC) 4th Annual Joint Retreat/Conference $47,538
Children’s Hospital of Los Angeles Alan S Wayne Conference II The American Society for Transplantation and Cellular Therapy (ASTCT)/The European Society for Blood and Marrow Transplantation (EBMT) 6th International Conference on Relapse after Transplant and Cellular Therapy $50,000
Global Genes Nicole Boice Conference II Global Genes Rare Advocacy Summit $50,000
Stanford University Dr Ngan F Huang Conference II Bay Area Stanford Regenerative Medicine Conference for Students—A TERMIS-AM Ambassador’s Conference $3,320
Fate Therapeutics, Inc. Bob Valamehr Clinical Trial Stage Projects A Phase 1 Study of FT819 in Participants with Moderate to Severe Active Systemic Lupus Erythematosus $7,934,448
Senti Biosciences, Inc. Rochelle Emery Clinical Trial Stage Projects Selective, Off-the-Shelf Logic Gated CAR NK Cell Therapy Targeting CD33 and/or FLT3 Expressing Hematologic Malignancies $8,000,000
ImmPACT-Bio, Inc. DR Jonathan Benjamin Clinical Trial Stage Projects A phase 1/2 study to evaluate a bispecific CD19/CD20-directed CAR T cell, in refractory lupus nephritis and systemic lupus erythematosus $8,000,000
University of California, San Francisco Dr. Hideho Okada Clinical Trial Stage Projects Phase 1 Study of Autologous E-SYNC T Cells in Adult Participants with EGFRvIII+ Glioblastoma $10,927,618
Aspen Neuroscience Dr. Edward Wirth III Clinical Trial Stage Projects Phase 1/2a Dose Escalation Study of ANPD001 in Sporadic Parkinson Disease $8,000,000
Allogene Therapeutics Dr. John Le Gall Clinical Trial Stage Projects A PHASE 1B STUDY EVALUATING THE SAFETY AND EFFICACY OF AN ALLOGENEIC CELL THERAPY IN SUBJECTS WITH CLEAR CELL RENAL CELL CARCINOMA (ccRCC) $15,000,000
University of California, San Francisco Noriyuki Kasahara Clinical Trial Stage Projects A Phase I/IIa Study to Evaluate the Efficacy of Toca 511/Toca FC with Standard of Care Therapy in Newly Diagnosed High Grade Glioma $11,807,220
Luxa Biotechnology Dr. Jeffrey H Stern Clinical Trial Stage Projects RPESC-RPE-4W Therapy for dry Age-related Macular Degeneration $4,009,675
Rocket Pharmaceuticals, Inc. Dr. Jonathan Schwartz Clinical Trial Stage Projects A Phase 2 Study Evaluating the Efficacy and Safety of IV Administered rAAV9 Vector Containing RP-A501 in Male Patients with Danon Disease $5,808,735
University of California, Davis Dr. Diana L. Farmer Clinical Trial Stage Projects The CuRe Trial: Cellular Therapy for In Utero Repair of Myelomeningocele $8,996,477
City of Hope, Beckman Research Institute Elizabeth Budde Clinical Trial Stage Projects Phase I Study of Chimeric Antigen Receptor Engineered T Cells targeting CD33 for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia $11,983,547
Stanford University Dr. Reena Parada Thomas Clinical Trial Stage Projects Phase I Trial of Locoregionally Delivered Autologous B7-H3 CAR T Cells (B7-H3CART) in Adults with Recurrent Glioblastoma Multiforme $11,999,991
University of California, San Diego Prof. Olivia Kim-McManus Clinical Trial Stage Projects Personalized antisense oligonucleotide therapy for rare pediatric genetic disease: SCN2A $960,713
Stanford University Anusha Kalbasi Clinical Trial Stage Projects Stem-Derived IL13Ra2 Chimeric Antigen Receptor T cells for Patients with Melanoma and Advanced Solid Tumors $10,211,085
Regenerative Patch Technologies LLC Dr Jane S Lebkowski Clinical Trial Stage Projects A Phase 2b, Randomized, Assessor-Masked Clinical Trial to Assess the Safety and Efficacy of the CPCB-RPE1 Implant in Subjects with Geographic Atrophy $12,373,748
City of Hope, Beckman Research Institute Dr. Angelo Manuel Almeida Cardoso Ph.D., MD Clinical Trial Stage Projects Evaluation of Safety and Feasibility of Cytomegalovirus-Specific, Anti-HIV Chimeric Antigen Receptor (CMV/HIV-CAR) T Cells in People with HIV $11,299,976
Combangio, Inc. R. Kim Brazzell Clinical Trial Stage Projects Phase 2b Clinical Study of KPI-012 Topical Ophthalmic Human Mesenchymal Stem Cell Secretome for the Treatment of Persistent Corneal Epithelial Defect $15,000,000
Immusoft Corporation Dr Robert Hayes Clinical Trial Stage Projects A Phase I Open Label Study to Evaluate the Safety and Tolerability of ISP-001 in Patients with Mucopolysaccharidosis Type 1 $8,000,000
Eureka Therapeutics, Inc. Pei Wang Clinical Trial Stage Projects Autologous ARTEMIS® T Cells to Treat Refractory/Relapsed Pediatric Liver Cancer $10,600,072
Stanford University Dr. Matthew H Porteus Clinical Trial Stage Projects Reduced intensity conditioning with JSP191 prior to TCRαβ+ T-cell/CD19+ B-cell depleted hematopoietic stem cell transplant for Fanconi Anemia patients $10,642,420
Angiocrine Bioscience, Inc. Dr. Paul Finnegan Clinical Trial Stage Projects AB-205-301 Phase 3 Trial and Related Activities to Support Clinical Development of AB-205 $10,930,014
Tachyon Therapeutics, Inc Ivan King Clinical Trial Stage Projects TACH101: A Potent, First-In-Class KDM4 Inhibitor for Advanced Cancers $6,862,609
Genascence Corporation Dr. Thomas W Chalberg Jr. Clinical Trial Stage Projects A Phase 1b, Randomized, Blinded, Placebo-Controlled Dose-Ranging Study of GNSC-001 Evaluating Safety, Pharmacodynamics, and Biomarkers in Knee OA $11,637,194
City of Hope, Beckman Research Institute Ryotaro Nakamura Clinical Trial Stage Projects Treatment of Severe Aplastic Anemia by induction of mixed chimerism using CD4+ T cell depleted haploidentical donor stem cell transplant $9,054,216
Neurona Therapeutics Dr. Cory R Nicholas Clinical Trial Stage Projects Phase 1/2 Study of NRTX-1001 Neural Cell Therapy in Subjects with Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy $7,999,999
Stanford University Alice Bertaina Clinical Trial Stage Projects Sequential same donor αβdepleted-HSCT from an HLA-partially matched donor allowing immunosuppression free kidney transplant $11,998,188
Excision BioTherapeutics William Kennedy Clinical Trial Stage Projects Phase 1 Clinical research program for functional cure of HIV with EBT-101, in-vivo gene therapy $6,852,486
Wake Forest University Health Sciences James Yoo Clinical Trial Stage Projects Phase I Treatment of Urethral Strictures in Humans $3,841,593
City of Hope, Beckman Research Institute Dr Jana Portnow Clinical Trial Stage Projects A Phase I Study of Multiple doses of NSC-Based Oncolytic Virotherapy Administered Intracerebrally to Patients with Recurrent High-Grade Gliomas $11,999,984
Stanford University Dr. Rosa Bacchetta Clinical Trial Stage Projects Phase 1 Study of Autologous CD4LVFOXP3 in Participants with IPEX Syndrome $11,999,179
University of California, Davis Peter C Belafsky Clinical Trial Stage Projects A Double-Blind Randomized Placebo-Controlled Investigation of Autologous Muscle Derived Progenitor Cells for the Treatment of Dysphagia $11,015,936
BioEclipse Therapeutics INC. Dr. Pamela Reilly Contag Clinical Trial Stage Projects PHASE 1, OPEN LABEL, DOSE-ESCALATION STUDY OF CRX100 IN PATIENTS WITH ADVANCED SOLID TUMORS $7,999,689
Stanford University Crystal Mackall Clinical Trial Stage Projects Phase 1 Clinical Trial of Autologous GD2 Chimeric Antigen Receptor T Cells for Diffuse Intrinsic Pontine Gliomas and Spinal Diffuse Midline Glioma $11,998,310
Stanford University Dr. Joseph C. Wu Clinical Trial Stage Projects A Phase I, Pilot Study of Human Embryonic Stem Cell-Derived Cardiomyocytes in PaTients with ChrOnic Ischemic Left VentRicular Dysfunction (HECTOR) $6,987,507
Stanford University Dr. Matthew H Porteus Clinical Trial Stage Projects Phase 1/1b study of T-allo10 infusion after HLA-partially matched abdepleted-HSCT in children and young adults with hematologic malignancies. $10,563,822
Cedars-Sinai Medical Center Clive Svendsen Clinical Trial Stage Projects CNS10-NPC-GDNF delivered into the motor cortex for the treatment of ALS $11,990,372
Stanford University Dr. Gary Steinberg Clinical Trial Stage Projects Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects with Chronic Ischemic Subcortical Stroke $11,998,988
City of Hope, Beckman Research Institute Dr. Leo D Wang Clinical Trial Stage Projects Phase I Study of IL13Rα2-Targeting CAR T Cells After Lymphodepletion for Children with Refractory or Recurrent Malignant Brain Tumors $8,401,309
University of California, San Francisco Steven G. Deeks Clinical Trial Stage Projects Anti-HIV duoCAR-T cell therapy for HIV infection $8,970,732
Brain Neurotherapy Bio Krystof S. Bankiewicz Clinical Trial Stage Projects A Phase 1b Safety Study for MRI guided delivery of AAV2-GDNF for the treatment of Parkinson’s disease $5,510,462
University of California, Los Angeles Dr. Sophie X Deng Clinical Trial Stage Projects Safety and Feasibility of Cultivated Autologous Limbal Stem Cells for Limbal Stem Cell Deficiency $10,301,486
Cedars-Sinai Medical Center Clive Svendsen Clinical Trial Stage Projects Clinical Study to Assess Safety and Efficacy of Subretinal Injection of Human Neural Progenitor Cells for Treatment of Retinitis Pigmentosa $10,444,063
1 2 3 4 5 6 7